Outcomes in patients with nontriple antiphospholipid syndrome (APS) anticoagulated with rivaroxaban

Saved in:
Bibliographic Details
Published inInternational journal of laboratory hematology Vol. 43; no. 5; pp. e252 - e253
Main Authors Htut, Thura Win, Milne, Denis, Khan, Mohammed M., Watson, Henry G.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.10.2021
Subjects
Online AccessGet full text

Cover

Loading…
Author Htut, Thura Win
Khan, Mohammed M.
Milne, Denis
Watson, Henry G.
Author_xml – sequence: 1
  givenname: Thura Win
  orcidid: 0000-0002-5508-1472
  surname: Htut
  fullname: Htut, Thura Win
  organization: Foresterhill Health Campus
– sequence: 2
  givenname: Denis
  surname: Milne
  fullname: Milne, Denis
  organization: Foresterhill Health Campus
– sequence: 3
  givenname: Mohammed M.
  surname: Khan
  fullname: Khan, Mohammed M.
  organization: Foresterhill Health Campus
– sequence: 4
  givenname: Henry G.
  surname: Watson
  fullname: Watson, Henry G.
  email: henry.watson@nhs.scot
  organization: Foresterhill Health Campus
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33470532$$D View this record in MEDLINE/PubMed
BookMark eNp9kF1LwzAYhYNMdFNv_AFS8GYK03w27eUY6iYDBRW8C2mauYwuqUnr3L83WvXCCwMhL-Q55z2cAehZZzUAxwheoHguzapaXiBCU7oD-ogzNGKMPPd-Z4z2wSCEFYSMU5jvgX1CKIeM4D5Qd22j3FqHxNiklo3RtgnJxjTLJG5pvKkrnUjbmHrpQryVqU2ZhK0tfVQlw_H9w9nXv3Lypa1ko8tO7c2b9O5dFtIegt2FrII--n4PwNP11eNkOprf3cwm4_lIkRhslCvEOVQYZ3mZS4yLgkmZxcSapCyjsMQqzSCkqJScpIQSGCFN4AKqSLKCHIBh51t799rq0Ii1CUpXlbTatUFgynOKUcphRE__oCvXehvTCcx4mkYsQ5E67yjlXQheL0TtzVr6rUBQfFYvPqsXX9VH-OTbsi3WuvxFf7qOAOqAjan09h8rMbudTzvTDwrekAU
CitedBy_id crossref_primary_10_1007_s10557_023_07496_3
Cites_doi 10.1182/blood-2018-04-848333
10.1016/j.jaut.2010.06.015
10.1056/NEJMoa1300615
10.1111/j.1538-7836.2011.04532.x
10.1111/j.1538-7836.2005.01394.x
10.1016/S2352-3026(16)30079-5
10.1111/j.1538-7836.2005.01204.x
10.1111/jth.14935
10.1136/annrheumdis-2019-215213
10.1006/jaut.2000.0409
10.1111/j.1365-2141.2012.09037.x
10.1111/jth.14237
ContentType Journal Article
Copyright 2021 John Wiley & Sons Ltd
Copyright © 2021 John Wiley & Sons Ltd
Copyright_xml – notice: 2021 John Wiley & Sons Ltd
– notice: Copyright © 2021 John Wiley & Sons Ltd
DBID NPM
AAYXX
CITATION
7T5
H94
7X8
DOI 10.1111/ijlh.13464
DatabaseName PubMed
CrossRef
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1751-553X
EndPage e253
ExternalDocumentID 10_1111_ijlh_13464
33470532
IJLH13464
Genre letter
Letter
Commentary
Editorial
Correspondence
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OC
29J
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
Q~Q
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
~IA
~WT
NPM
AAYXX
CITATION
7T5
H94
7X8
ID FETCH-LOGICAL-c3574-9c1770c2289d9a22bb5aa8740e365840d2c680041da7363430a22e30f0cb5a5b3
IEDL.DBID DR2
ISSN 1751-5521
IngestDate Fri Aug 16 10:26:44 EDT 2024
Thu Oct 10 20:11:10 EDT 2024
Fri Aug 23 01:14:52 EDT 2024
Sat Sep 28 08:25:09 EDT 2024
Sat Aug 24 00:59:57 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords antiphospholipid syndrome
rivaroxaban
venous thromboembolism
anticoagulation
warfarin
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3574-9c1770c2289d9a22bb5aa8740e365840d2c680041da7363430a22e30f0cb5a5b3
Notes SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ORCID 0000-0002-5508-1472
PMID 33470532
PQID 2576642181
PQPubID 2045143
PageCount 2
ParticipantIDs proquest_miscellaneous_2479421670
proquest_journals_2576642181
crossref_primary_10_1111_ijlh_13464
pubmed_primary_33470532
wiley_primary_10_1111_ijlh_13464_IJLH13464
PublicationCentury 2000
PublicationDate October 2021
PublicationDateYYYYMMDD 2021-10-01
PublicationDate_xml – month: 10
  year: 2021
  text: October 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
PublicationTitle International journal of laboratory hematology
PublicationTitleAlternate Int J Lab Hematol
PublicationYear 2021
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_1_6_10_1
e_1_2_1_6_12_1
e_1_2_1_6_11_1
e_1_2_1_6_7_1
e_1_2_1_6_6_1
e_1_2_1_6_9_1
e_1_2_1_6_8_1
e_1_2_1_6_3_1
e_1_2_1_6_2_1
e_1_2_1_6_13_1
e_1_2_1_6_5_1
e_1_2_1_6_4_1
References_xml – ident: e_1_2_1_6_7_1
  doi: 10.1182/blood-2018-04-848333
– ident: e_1_2_1_6_10_1
  doi: 10.1016/j.jaut.2010.06.015
– ident: e_1_2_1_6_13_1
  doi: 10.1056/NEJMoa1300615
– ident: e_1_2_1_6_11_1
  doi: 10.1111/j.1538-7836.2011.04532.x
– ident: e_1_2_1_6_6_1
  doi: 10.1111/j.1538-7836.2005.01394.x
– ident: e_1_2_1_6_8_1
  doi: 10.1016/S2352-3026(16)30079-5
– ident: e_1_2_1_6_9_1
  doi: 10.1111/j.1538-7836.2005.01204.x
– ident: e_1_2_1_6_12_1
  doi: 10.1111/jth.14935
– ident: e_1_2_1_6_2_1
  doi: 10.1136/annrheumdis-2019-215213
– ident: e_1_2_1_6_3_1
  doi: 10.1006/jaut.2000.0409
– ident: e_1_2_1_6_4_1
  doi: 10.1111/j.1365-2141.2012.09037.x
– ident: e_1_2_1_6_5_1
  doi: 10.1111/jth.14237
SSID ssj0057409
Score 2.3191435
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage e252
SubjectTerms anticoagulation
Antiphospholipid syndrome
rivaroxaban
venous thromboembolism
warfarin
Title Outcomes in patients with nontriple antiphospholipid syndrome (APS) anticoagulated with rivaroxaban
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fijlh.13464
https://www.ncbi.nlm.nih.gov/pubmed/33470532
https://www.proquest.com/docview/2576642181
https://search.proquest.com/docview/2479421670
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEB_EB-lL_eiHqVa2tA-tkGOzm2Qv0BfRylVqK1bBlxL26zBWcoe588G_vjOb5FpbKOhDILCz2Y_ZyczOzv4G4J3IlRsbocivkcUp2vRxIYyJsyLzY-k515YuOB9_zUfn6dFFdrEEH_u7MC0-xMLhRpIR_tck4No0fwh5dXV9OUhkmhMYaCIVxXMdnC6wozKVhvgOVI9JnKGS6rBJKYznd9X72ugfE_O-xRpUzuEq_Og720aa_BzMZ2Zg7_7CcXzsaNbgaWeLsr128azDkq83YOW4O21_BvbbfIbf8Q2ratYBsDaMPLespgh38tEz5Ew1vZw0-FxX08qxHgOBvd87-f4hlNuJDhnvvWtr31S3Ggelja6fw_nhp7P9UdwlZYitxDmNC5soxa3AjZortEC-ZlpTXj8vyZjhTth8SCheTiuZy1RyJPKSj7lFyszIF7CMffSbwArhjNBDU3jl03HBh9Zz5bhDk8jawrkI3vbMKact9kbZ71lovsowXxFs93wrO_lrStpG0RXeYRLBm0UxSg4dh-jaT-ZIQ-D6IskVj-Bly-9FM1KminJmRLAbuPaf9svPR19G4e3VQ4i34Img8JgQF7gNy7ObuX-N9s3M7IR1_AsrbPYj
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NIQEvDBgbgQ2M4GFMSuXYSdw8TvtQN9qBYJP2FvmrWmBKq6Xlgb-eOyctbEiT4CFSJJ_jj_Plzufz7wDei1y5sRGK_BpZnKJNHxfCmDgrMj-WnnNt6YLz6DQfnKcnF9lFF5tDd2FafIilw40kI_yvScDJIf2HlFffri57iUzz9B7cR3mXlLnh4MsSPSpTaYjwQAWZxBmqqQ6dlAJ5fte9qY_-MjJv2qxB6RyttZlVm4BVSLEm33vzmenZn7eQHP97PE_gcWeOsr12_TyFFV8_gwej7sB9Heyn-Qw_5BtW1azDYG0YOW9ZTUHu5KZnyJxqejlp8LmqppVjCxgEtrP3-euHUG4nOiS9966tfV390DgqbXT9HM6PDs_2B3GXlyG2Eic1LmyiFLcC92qu0AJZm2lNqf28JHuGO2HzPgF5Oa1kLlPJkchLPuYWKTMjN2AV--hfACuEM0L3TeGVT8cF71vPleMOrSJrC-cieLfgTjlt4TfKxbaF5qsM8xXB1oJxZSeCTUk7KbrF208ieLssRuGhExFd-8kcaQhfXyS54hFstgxfNiNlqihtRgS7gW13tF8enwwH4e3lvxC_gYeDs9GwHB6ffnwFjwRFy4QwwS1YnV3P_TaaOzPzOizqX36Y-js
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVceD8CBYzgAEhZObYTbyQuFbDalrZUQKVeUORX1ECVXXV3OfDrmXGShYKEBIdIkWzHj_FkPo_HnwGeiUL72gpNfo08VYjp01JYm-ZlHmoZODeODjgfHBbTY7V3kp9swKvhLEzHD7F2uJFmxP81Kfjc178oefPl7HSUSVWoS3BZFQh9CRJ9WJNH5VrFAA-0j1mao5XqyUkpjudn2Yvm6A-MeRGyRpszuQafh9Z2oSZfR6ulHbnvvxE5_m93rsPVHoyynW723ICN0N6ErYN-u_0WuPerJX4nLFjTsp6BdcHIdctaCnEnJz1D0TTz09kCn7Nm3ng2kCCw5ztHH1_EdDcz8cr74LvS5803g50y1rS34Xjy9tPradrfypA6iWOali7TmjuBKzVfGoGCzY2hi_2CJDTDvXDFmGi8vNGykEpyzBQkr7nDnLmVd2AT2xjuASuFt8KMbRl0UHXJxy5w7blHTORc6X0CTwfhVPOOfKMaFi00XlUcrwS2B7lVvQIuKlpH0RnecZbAk3Uyqg7th5g2zFaYh9j1RVZonsDdTt7raqRUmi7NSOBllNpf6q929_an8e3-v2R-DFtHbybV_u7huwdwRVCoTIwR3IbN5fkqPESss7SP4pT-AZrz-Oo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Outcomes+in+patients+with+nontriple+antiphospholipid+syndrome+%28APS%29+anticoagulated+with+rivaroxaban&rft.jtitle=International+journal+of+laboratory+hematology&rft.au=Thura+Win+Htut&rft.au=Milne%2C+Denis&rft.au=Khan%2C+Mohammed+M&rft.au=Watson%2C+Henry+G&rft.date=2021-10-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1751-5521&rft.eissn=1751-553X&rft.volume=43&rft.issue=5&rft.spage=e252&rft.epage=e253&rft_id=info:doi/10.1111%2Fijlh.13464&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1751-5521&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1751-5521&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1751-5521&client=summon